TOA International ROP Course Theoretical Course Program | ||
07:30 - 08:00 | REGISTRATİON | |
08:00 - 09:30 | PART I | |
Moderators: | ||
08:00 - 08:15 | Opening | |
08:15 - 08:25 | History and incidence of ROP | |
08:25 - 08:40 | Embryonal development of the retina and Pathogenesis of ROP | |
08:40 - 08:45 | DISCUSSION | |
08:45 - 08:55 | Systemic, environmental and genetic factors that predispose to the development of ROP | |
08:55 - 09:05 | ROP Screening Procedure: Concerns and Complications, Ideal environment for ROP examination and treatment | |
09:05 - 09:15 | Unique ocular features of ROP | |
09:15 - 09:25 | DISCUSSION | |
09:30 - 10:20 | PART II | |
Moderators: | ||
09:30 - 09:40 | Tips to use indirect ophthalmoscopy for ROP screening | |
09:40 - 09:50 | Wide-angle systems for ROP Screening | |
10:20 - 10:20 | DISCUSSION | |
10:20 - 10:40 | BREAK | |
10:40 - 12:00 | PART III | |
Moderators: | ||
10:45 - 11:00 | Basic ROP classification and definitions (before ICROP-3) | |
11:00 - 11:15 | ICROP -3 | |
11:15 - 11:20 | DISCUSSION | |
11:20 - 11:30 | Setting up an ROP screening program and Creating national ROP Guidelines: Steps and process | |
11:30 - 11:40 | Screening: To Whom? When? How often? | |
11:40 - 11:50 | Artificial intelligence and ROP | |
11:50 - 12:00 | DISCUSSION | |
12:00 - 13:00 | PART IV | |
Moderators: | ||
12:00 - 12:10 | Prospective Randomized Controlled ROP StudiesProspective Randomized Controlled ROP Studies (Pre-Anti-VEGF) | |
12:10 - 12:20 | Prospective Randomized Controlled ROP Studies (Post Anti-VEGF) | |
12:20 - 12:30 | Criteria for Treatment and Selection of treatment methods | |
12:30 - 12:40 | Treatment of ROP outside the guidelines | |
12:40 - 12:50 | A-ROP and Oxygen associated retinopathy | |
12:50 - 13:00 | DISCUSSION | |
13:00 - 14:00 | LUNCH | |
14:00 - 15:05 | PART V | |
Moderators: | ||
14:00 - 14:10 | Pediatric Anesthesia in Premature Infants: Challenges, Risks, and Best Practices – Lessons Learned | |
14:10 - 14:25 | Tips for laser treatment | |
14:25 - 14:35 | Follow-up and Retreatment criteria after laser therapy | |
14:35 - 14:45 | Complications and management after laser therapy | |
14:55 - 15:05 | DISCUSSION | |
15:05 - 16:35 | PART VI | |
Moderators: | ||
15:05 - 15:20 | From RCT to real world: the use of antiVEGF in the management of ROP | |
15:20 - 15:35 | SAFER injection protocol | |
15:35 - 15:50 | Follow-up after Anti-VEGF treatment and retreatment criteria | |
15:50 - 16:05 | Managing PAR | |
16:05 - 16:15 | Systemic safety related to ROP treatment | |
16:15 - 16:25 | Role of FFA in Acute and late ROP, Techniques for Capturing the Best Images | |
16:25 - 16:35 | Persistent Vascular Anomalies in Retinopathy of Prematurity Children: Ultra-Widefield Fluorescein Angiography Findings until School Age | |
16:35 - 16:45 | DISCUSSION | |
16:30 - 16:35 | Industry presentation 1: | |
16:35 - 16:50 | BREAK | |
16:50 - 17:40 | PART VII | |
16:50 - 17:40 | Moderators: | |
16:50 - 17:05 | Surgery for stage 4 ROP: indications, timing, technique, long term results | |
17:05 - 17:20 | Surgery in Stage 5 and cicatricial ROP | |
17:20 - 17:30 | Surgical tips for ROP | |
17:30 - 17:35 | DISCUSSION | |
17:35 -17:40 | Industry presentation 2: |
2.nd DAY (03.10.2025) TODEM İSTANBUL |
||
08:00 - 10:00 | PART VIII | |
Moderators: | ||
08:00 - 08:15 | Differential diagnosis: (FEVR, Norrie, Incontinentia Pigmenti, PFV, Coats) | |
08:15 - 08:30 | Non-ROP neonatal retinal diseases seen during ROP care and unusual forms of ROP | |
08:30 - 08:40 | DISCUSSION | |
08:40 - 08:55 | Challenges in ROP screening and treatment (Premature infants with corneal opacity /2. Infants with non-dilated pupils /3. Premature infants with congenital cataracts/4. Cases with active adenoviral conjunctivitis) | |
08:55 - 09:10 | Role of OCT in ROP and OCT biomarkers to predict ROP response to anti-VEGF | |
09:10 - 09:20 | Experimental treatments for ROP | |
09:20 - 09:30 | DISCUSSION | |
09:30 - 09:45 | Clinical Features and Visual Outcomes of Patients Developing Retinal Detachment, Vitreous Hemorrhage and Retinal Break in Adult Retinopathy of Prematurity: An International Multicenter Study | |
09:45 - 10:00 | ROP related RRD in Adolescent/Adults: Causes, Treatment, Precautions | |
10:00 - 10:10 | DISCUSSION | |
10:10 - 10:30 | BREAK | |
10:30 - 12:15 | PART IX | |
Moderators: | ||
10:30 - 10:45 | Strabismus in ROP survivors | |
10:45 - 11:00 | Challenges in refractive examination in ROP and Management of amblyopia | |
11:00 - 11:15 | Premature baby with Cataract: Management | |
11:15 - 11:30 | Aphakia and its management in ROP patients | |
11:30 - 11:45 | ROP and secondary Glaucoma: causes, precautions and management | |
11:45 - 12:00 | DISCUSSION | |
11:40 - 11:55 | Evaluation of vision in visually-impaired infants and children | |
11:55 - 12:05 | Visual habilitation in premature infants | |
11:55 - 12:05 | Ophthalmological impairment at 5 y old in preterm infants | |
12:05 - 12:15 | DISCUSSION | |
12:15 - 13:15 | LUNCH | |
13:15 - 15:00 | PART X | |
Moderators: | ||
13:15 - 13:25 | How to set up an ROP training program | |
13.25 - 13:45 | AAO Virtual Reality Center- Virtual ROP examination, retinal laser and intra-vitreal injection training simulator | |
13:45 - 14:45 | Panel: Case Discussions and Medicolegal Issues (Interactive Panel with sample cases) |
|
14:45 - 14:55 | BREAK | |
14:55 - 15:35 | THEORETICAL EXAM | |
19:30 | GALA DINNER & CERTIFICATE / DOCUMENT CEREMONY |
3.rd DAY (0410.2025) TODEM İSTANBUL 08:00-17:00 SKILL TRANSFER DRY LABS |
||
The trainees will simultaneously receive training for 120 minutes in four rooms in four small groups. After each course, there will be a 10-minute break and the trainees will move to the next room. |
||
1. COURSE | 08:00 - 10:00 | |
BREAK | 10:00 - 10:10 | |
2. COURSE | 10:10 - 12:10 | |
LUNCH | 12:10 - 13:00 | |
3. COURSE | 13:00 - 15:00 | |
BREAK | 15:00 - 15:10 | |
4. COURSE | 15:10 - 17:10 |
1- STL: Neonatal Resuscitation |
2- STL: Indirect ophthalmoscopic examination with Eyesi Indirect Ophthalmoscopy Simulator
(Optik principles, Lenses, examination of the posterior pole and peripheral retina)
|
3- STL A: Laser application to phantom eyes STL B: Intravitreal injection to phantom eyes STL C: Basic Retinoscopy |
4- STL: Clinical case discussions with slides |
“The Scientific program may be subject to change.”